Characteristics Contributing to Survival Differences Between Black and White Patients Following Cystectomy [0.03%]
导致黑色人种和白色人种膀胱全切术后生存期差异的因素分析
Shoshana J Rosenzweig,Daniel Ranti,Reza Mehrazin et al.
Shoshana J Rosenzweig et al.
Purpose: Examine patient, tumor, and treatment characteristics effect on the disparity between black and white patients with muscle-invasive bladder cancer (MIBC) who undergo radical cystectomy (RC). ...
Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations [0.03%]
在服务医疗不平等待遇人群的医院系统中，中期和高危前列腺癌患者接受最终治疗的情况及其生存率
David-Dan Nguyen,Muhieddine Labban,Logan Briggs et al.
David-Dan Nguyen et al.
Introduction: Although socioeconomic and racial disparities in prostate cancer (CaP) have been attributed to patient-level and physician-level factors, there is growing interest in investigating the role of the facility o...
Prevalence and Morbidity of Local Treatment-Related Side Effects in Metastatic Prostate Cancer Patients [0.03%]
转移性前列腺癌患者的局部治疗相关副作用的发病率和疾病负担
Daniel Sentana-Lledo,Laura E Dodge,Peter Chang et al.
Daniel Sentana-Lledo et al.
Purpose: Treatment toxicity from surgery radical prostatectomy (RP) or radiation therapy (RT) has been well studied in patients with localized prostate cancer. However, little is known about lingering toxicities in patien...
Low risk is low risk, regardless of race or ethnicity: Outcomes of prostate cancer active surveillance and factors associated with reclassification in a racially diverse cohort [0.03%]
低风险就是低风险，无论种族或族裔：前列腺癌主动监测的结局及其与重新分层相关的因素在一个种族多样化的队列中的情况
Kevin Labagnara,Denzel Zhu,Justin Loloi et al.
Kevin Labagnara et al.
Introduction: Active surveillance (AS) is the standard for very low- and low-risk prostate cancer. Although risk factors for pathologic reclassification while on AS have been identified, results are mixed for non-Hispanic...
Folawiyo Laditi,James Nie,Walter Hsiang et al.
Folawiyo Laditi et al.
Background: The expansion of state Medicaid programs associated with the Affordable Care Act has led to significant increases in insurance coverage for economically vulnerable patients, however barriers to accessing cance...
Preliminary results regarding automated identification of patients with a limited six-month survival prognosis using nursing assessment in uro-oncology patients [0.03%]
基于护理评估的泌尿系统肿瘤患者半年生存期自动化预测的初步研究结果
Carmen Roch,Julian Alexander Kielkopf,Ulrich Stefenelli et al.
Carmen Roch et al.
Introduction: Contrary to current recommendations, palliative co-management of tumor patients often occurs late in daily clinical practice. Palliative care specialist (PCS) co-management should be considered at the latest...
The impact of life expectancy on cost-effectiveness of treatment options for clinically localized prostate cancer [0.03%]
预期寿命对局限性前列腺癌治疗选择的成本效益分析的影响
Aurash Naser-Tavakolian,Abhishek Venkataramana,Brennan Spiegel et al.
Aurash Naser-Tavakolian et al.
Background: Life expectancy (LE) impacts effectiveness and morbidity of prostate cancer (CaP) treatment, but its impact on cost-effectiveness is unknown. We sought to evaluate the impact of LE on the cost-effectiveness of...
Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer [0.03%]
肌层浸润性膀胱癌的盆腔淋巴结联合膀胱放化疗与单独膀胱放化疗对比研究
Sagar A Patel,Yuan Liu,Abhishek A Solanki et al.
Sagar A Patel et al.
Background: Bladder-sparing chemoradiation therapy (CRT) is a definitive first-line treatment for muscle-invasive bladder cancer. The optimal radiotherapy target volume, either bladder-only (BO) or bladder plus pelvic lym...
Age related differences in primary testicular lymphoma: A population based cohort study [0.03%]
基于人群的队列研究中初级睾丸淋巴瘤的年龄差异特征
Mohamad B Berjaoui,Jaime O Herrera-Caceres,Tiange Li et al.
Mohamad B Berjaoui et al.
Introduction: Primary testicular non-Hodgkin's lymphoma (PTL) is a very rare disease, comprising 1% of all non-Hodgkin's lymphoma and 60 years. There is limited published data on PTL incidence and outcomes in younger pati...
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1 [0.03%]
新辅助治疗后的保膀胱-2021 IBCN更新第一部分
Patrick J Hensley,Roland Seiler,Harry Herr et al.
Patrick J Hensley et al.
The morbidity associated with radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC) has fueled investigations into the feasibility of bladder preservation strategies after a favorable clinical response to neoadjuvant therapy (NA...